Cardiotoxic Electrical Impedance Safety Screening
Cambridge Bioscience offers access to a service for continuous and precise screening of drug cardiotoxic effects from B’SYS using induced pluripotent stem cell derived cardiomyocytes. This service aims to identify cardiotoxic effects earlier during drug development and consequently avoid the significant costs, both in terms of human health and resource allocation, associated with late candidate drug failure.
B'SYS uses the CardioExcyte96 for impedance based safety testing.
Contact Our Specialists
To discuss a cardiotoxic electrical impedance safety screening project, please contact our B'SYS specialist by Clicking Here